Axi-cel in refractory large B-cell lymphoma, effects of C1 inhibitor deficiency on coagulation, and the evolution of therapy-related myeloid neoplasms
Blood Podcast
00:00
Introduction
This week, we look at the findings from a five-year follow-up study of axocaptogen sililucil in refractory large B-cell lymphoma. We also discuss the role of C1 inhibitor deficiency in coagulation and venous thrombosis. And learn how chemotherapy signatures can be used to track the evolution of therapy-related myeloid neoplasms.
Transcript
Play full episode
